Naviswiss closed a CHF 5 million (USD $5 million) round of private equity funding to support product development and entrance into new markets with its surgical navigation for joint replacement procedures.
Zebra Medical Vision and DePuy Ireland entered into a global co-development and commercialization agreement to bring artificial intelligence opportunities to orthopedics.
Conventus Orthopaedics expanded into lower extremity orthopedics with an acquisition of all assets of IntraFuse, including proprietary intramedullary implants for the minimally invasive repair of fibula and other fractures.Â
Bioventus secured preferred access to DUROLANE, GELSYN-3 and SUPARTZ FX to treat knee OA pain for certain Blue Cross Blue Shield of Michigan patients.Â
Parvizi Surgical Innovation made a minority investment in Navbit, developer of a disposable, single-use surgical navigation system to support accurate positioning of the acetabular cup during hip replacement.Â
RSIP Vision debuted an artificial intelligence-based total hip replacement solution that provides an automated 3D structure of the hip joint for surgical planning.